CBAT vs. ARCT

In the year-to-date period, CBAT achieves a -4.27% return, which is significantly higher than ARCT's -35.30% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for CBAK Energy Technology, Inc. (CBAT) and Arcturus Therapeutics Holdings Inc. (ARCT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CBAT Sharpe Ratio is -0.25, which is higher than the ARCT Sharpe Ratio of -0.76. The chart below compares the historical Sharpe Ratios of CBAT and ARCT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither CBAT nor ARCT has paid dividends to shareholders.

The maximum CBAT drawdown since its inception was -99.49%, which is greater than ARCT's maximum drawdown of -92.79%. Use the drawdown chart below to compare losses from any high point for CBAT and ARCT. For additional features, visit the drawdowns tool.

The current volatility for CBAK Energy Technology, Inc. (CBAT) is 17.58%, while Arcturus Therapeutics Holdings Inc. (ARCT) has a volatility of 19.36%. This indicates that CBAT experiences smaller price fluctuations and is considered to be less risky than ARCT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between CBAK Energy Technology, Inc. and Arcturus Therapeutics Holdings Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.